Related Experiment Video
Updated: Jan 29, 2026

Protocol for Isolating the Mouse Circle of Willis
Published on: October 22, 2016
Current status of growth hormone therapy in Prader-Willi syndrome
1a Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden charlotte.hoybye@karolinska.se.
Insights
Growth hormone (GH) treatment improves physical health and quality of life in Prader-Willi syndrome (PWS) patients. Careful monitoring is essential, but benefits often outweigh risks for this complex genetic disorder.
Area of Science:
- Endocrinology
- Genetics
- Pediatrics
Background:
- Prader-Willi syndrome (PWS) is a complex genetic disorder.
- PWS is characterized by hypotonia, hypogonadism, short stature, hyperphagia, obesity, cognitive, and behavioral issues.
- Abnormal body composition with excess fat and insufficient lean mass is typical, alongside impaired growth hormone (GH) secretion.
Purpose of the Study:
- To evaluate the efficacy and safety of GH treatment in children and adults with PWS.
- To highlight the benefits of GH therapy on growth, body composition, and overall well-being.
Main Methods:
- Review of existing literature on GH treatment in PWS patients.
- Analysis of outcomes including height, body composition, psychomotor functioning, physical activity, and quality of life.
Main Results:
- GH treatment in children with PWS improves height, head size, body composition, and psychomotor functioning.
- In adults with PWS, GH treatment enhances body composition, physical activity, and quality of life.
- Restricted diet and exercise remain crucial alongside GH therapy.
Conclusions:
- GH treatment is beneficial for individuals with genetically confirmed PWS, regardless of cognitive disabilities or scoliosis.
- Careful monitoring of glucose metabolism and respiration is necessary due to potential adverse effects.
- GH therapy should be continued when benefits exceed the risks.
Abstract:
Prader-Willi syndrome (PWS) is a complex genetic disorder characterized by muscular hypotonia, hypogonadism, short stature, hyperphagia, obesity, cognitive disabilities and behavioral problems. Body composition is abnormal and growth hormone (GH) secretion is insufficient with more body fat than lean body mass. In children with PWS treatment with GH improves height, head size, body composition and psychomotor functioning. In adults with PWS treatment with GH improves body composition, physical activity and quality of life. However, restricted diet and regular physical exercise are cornerstone treatments in PWS also during GH treatment. GH treatment should be considered in PWS patients with a genetically confirmed diagnosis. Cognitive disabilities and scoliosis are not contraindications to GH treatment. Adverse effects to GH treatment in PWS are few, but glucose metabolism and changes in respiration must be monitored carefully, especially in individuals with predispositions. GH treatment should be continued as long as benefits outweigh the risks.
Related Concept Videos
Plant Hormones
Types of Hormones
Types of Hormones
Steroids and eicosanoids fall under the category of lipid-soluble hormones. Steroids are derived from cholesterol and feature four interconnected carbon rings with variable side chains. Notable examples include estradiol from ovaries and testosterone from testes, exemplifying the critical roles of these lipid-soluble hormones in reproductive physiology. Eicosanoids, derived...
Current Growth And Decay In RL Circuits
Hormonal Regulation
Hormonal Regulation

